CVS Health Corp Net Income

CVS Stock  USD 78.48  0.55  0.71%   
As of the 15th of February 2026, CVS Health shows the risk adjusted performance of 0.027, and Mean Deviation of 1.45. CVS Health Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CVS Health Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if CVS Health Corp is priced some-what accurately, providing market reflects its regular price of 78.48 per share. Given that CVS Health has jensen alpha of (0), we suggest you to validate CVS Health Corp's prevailing market performance to make sure the company can sustain itself at some point in the future.

CVS Health Total Revenue

422.17 Billion

CVS Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CVS Health's valuation are provided below:
Gross Profit
53.1 B
Profit Margin
0.0044
Market Capitalization
99.8 B
Enterprise Value Revenue
0.4191
Revenue
399.8 B
There are over one hundred nineteen available fundamental signals for CVS Health Corp, which can be analyzed over time and compared to other ratios. All traders should validate CVS Health's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 95.9 B in 2026. Enterprise Value is likely to gain to about 91.1 B in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Income1.8 B2.8 B
Net Income Applicable To Common Shares1.8 B1.7 B
Net Income From Continuing Ops1.7 B1.6 B
Net Income Per Share 1.40  1.62 
Net Income Per E B T 0.83  0.87 
At this time, CVS Health's Net Income is comparatively stable compared to the past year. Net Income Per Share is likely to gain to 1.62 in 2026, whereas Net Income Applicable To Common Shares is likely to drop slightly above 1.7 B in 2026.
  
Build AI portfolio with CVS Stock
The evolution of Net Income for CVS Health Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how CVS Health compares to historical norms and industry peers.

Latest CVS Health's Net Income Growth Pattern

Below is the plot of the Net Income of CVS Health Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CVS Health Corp financial statement analysis. It represents the amount of money remaining after all of CVS Health Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CVS Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVS Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.77 B10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

CVS Net Income Regression Statistics

Arithmetic Mean4,517,997,776
Coefficient Of Variation55.74
Mean Deviation1,882,826,146
Median4,614,000,000
Standard Deviation2,518,114,059
Sample Variance6340898.4T
Range8.9B
R-Value0.20
Mean Square Error6485962.5T
R-Squared0.04
Significance0.44
Slope101,035,533
Total Sum of Squares101454374.6T

CVS Net Income History

20262.6 B
20251.8 B
20244.6 B
20238.3 B
20224.3 B
2021B
20207.2 B

Other Fundumenentals of CVS Health Corp

CVS Health Net Income component correlations

CVS Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for CVS Health is extremely important. It helps to project a fair market value of CVS Stock properly, considering its historical fundamentals such as Net Income. Since CVS Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CVS Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CVS Health's interrelated accounts and indicators.
Is there potential for Health Care Providers & Services market expansion? Will CVS introduce new products? Factors like these will boost the valuation of CVS Health. Projected growth potential of CVS fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.766
Dividend Share
2.66
Earnings Share
1.39
Revenue Per Share
315.575
Quarterly Revenue Growth
0.084
Understanding CVS Health Corp requires distinguishing between market price and book value, where the latter reflects CVS's accounting equity. The concept of intrinsic value - what CVS Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push CVS Health's price substantially above or below its fundamental value.
It's important to distinguish between CVS Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CVS Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CVS Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

CVS Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CVS Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CVS Health.
0.00
11/17/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/15/2026
0.00
If you would invest  0.00  in CVS Health on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding CVS Health Corp or generate 0.0% return on investment in CVS Health over 90 days. CVS Health is related to or competes with BioAffinity Technologies, Artelo Biosciences, Revelation Biosciences, WORK Medical, GT Biopharma, Psyence Biomedical, and Protagenic Therapeutics. CVS Health Corporation provides health services in the United States More

CVS Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CVS Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CVS Health Corp upside and downside potential and time the market with a certain degree of confidence.

CVS Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for CVS Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CVS Health's standard deviation. In reality, there are many statistical measures that can use CVS Health historical prices to predict the future CVS Health's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CVS Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
76.1778.5680.95
Details
Intrinsic
Valuation
LowRealHigh
70.6386.5388.92
Details
28 Analysts
Consensus
LowTargetHigh
86.3094.84105.27
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.661.831.98
Details

CVS Health February 15, 2026 Technical Indicators

CVS Health Corp Backtested Returns

Currently, CVS Health Corp is very steady. CVS Health Corp secures Sharpe Ratio (or Efficiency) of 0.0186, which signifies that the company had a 0.0186 % return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for CVS Health Corp, which you can use to evaluate the volatility of the firm. Please confirm CVS Health's risk adjusted performance of 0.027, and Mean Deviation of 1.45 to double-check if the risk estimate we provide is consistent with the expected return of 0.0441%. CVS Health has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.84, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CVS Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding CVS Health is expected to be smaller as well. CVS Health Corp currently shows a risk of 2.37%. Please confirm CVS Health Corp value at risk, as well as the relationship between the skewness and day median price , to decide if CVS Health Corp will be following its price patterns.

Auto-correlation

    
  -0.46  

Modest reverse predictability

CVS Health Corp has modest reverse predictability. Overlapping area represents the amount of predictability between CVS Health time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CVS Health Corp price movement. The serial correlation of -0.46 indicates that about 46.0% of current CVS Health price fluctuation can be explain by its past prices.
Correlation Coefficient-0.46
Spearman Rank Test-0.2
Residual Average0.0
Price Variance7.37
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

CVS Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

426.3 Million

At this time, CVS Health's Accumulated Other Comprehensive Income is comparatively stable compared to the past year.
Based on the recorded statements, CVS Health Corp reported net income of 1.77 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.

CVS Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.
CVS Health is currently under evaluation in net income category among its peers.

CVS Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CVS Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CVS Health's managers, analysts, and investors.
Environmental
Governance
Social

CVS Health Institutional Holders

Institutional Holdings refers to the ownership stake in CVS Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of CVS Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CVS Health's value.
Shares
Morgan Stanley - Brokerage Accounts2025-06-30
17.3 M
Pzena Investment Management, Llc2025-06-30
16.7 M
T. Rowe Price Associates, Inc.2025-06-30
16.6 M
Charles Schwab Investment Management Inc2025-06-30
13.8 M
Northern Trust Corp2025-06-30
12.2 M
Davis Selected Advisers2025-06-30
11.6 M
Bank Of America Corp2025-06-30
9.8 M
Ubs Asset Mgmt Americas Inc2025-06-30
9.4 M
Capital Research Global Investors2025-06-30
9.2 M
Blackrock Inc2025-06-30
122.7 M
Vanguard Group Inc2025-06-30
120.4 M

CVS Fundamentals

About CVS Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.